Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > Lenvatinib Mesylate CAS 857890-39-2

Lenvatinib Mesylate CAS 857890-39-2

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 857890-39-2

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15 days

Payment Terms: T/T, L/C, D/A, Western Union

Supply Ability: TON

Get Best Price
Highlight:
CAS NO::
857890-39-2
Appearance::
White Powder
Molecular Formula::
C15H17N3O4
Molecular Weight::
303.313
EINECS NO::
N/A
MDL NO::
N/A
CAS NO::
857890-39-2
Appearance::
White Powder
Molecular Formula::
C15H17N3O4
Molecular Weight::
303.313
EINECS NO::
N/A
MDL NO::
N/A
Lenvatinib Mesylate CAS 857890-39-2

Product Description:

Product Name: Lenvatinib mesylate CAS NO:857890-39-2

 

 

 

 

 

 

 

 

 

Synonyms:

4-[3-chloro-4-(N'-cyclopropylureido)phenoxy]-7-methoxyquinoline-6-carboxamide mesylate;

 

 

 

 

 

 

 

Chemical & Physical Properties:

Appearance: white powder

Assay :≥99.0%

 

 

 

 

 

 

 

 

Lovatinib mesylate is the mesylate of levatinib. Lovatinib is a multi-target tyrosine kinase inhibitor developed by Eisai Japan. It has a novel binding mode. In addition to inhibiting other pro-angiogenic and oncogenic signaling pathways related tyrosine kinases involved in tumor proliferation, it can also selectively inhibit the kinase activity of vascular endothelial growth factor (VEGF) receptors, such as VEGF-1, VEGF-2 and VEGF- 3 etc.

 

 

 

 

 

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.